CLINICAL_TRIALS
research
· 2014-01-06
Clinical Trial Update: Traumatic Neuroprotection and Epilepsy Prevention of Valproate Acid [Phase 1]
Summary
Phase 1 clinical trial exploring valproic acid for neuroprotection and epilepsy prevention in patients with traumatic brain injury.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xijing Hospital | Conditions: Traumatic Brain Injury | Phase 1 | Status: UNKNOWN